Marine Compounds and Cancer: The First Two Decades of XXI Century

Sergey A Dyshlovoy; Friedemann Honecker

doi:10.3390/md18010020

Marine Compounds and Cancer: The First Two Decades of XXI Century

Mar Drugs. 2019 Dec 26;18(1):20. doi: 10.3390/md18010020.

Authors

Sergey A Dyshlovoy^{1

2

3

4}, Friedemann Honecker^{2

5}

Affiliations

¹ Laboratory of Pharmacology, A.V. Zhirmunski National Scientific Center of Marine Biology, Far Eastern Branch, Russian Academy of Sciences, 690041 Vladivostok, Russia.
² Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, Hubertus Wald-Tumorzentrum, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.
³ Laboratory of Biologically Active Compounds, Department of Bioorganic Chemistry and Biotechnology, School of Natural Sciences, Far Eastern Federal University, 690091 Vladivostok, Russia.
⁴ Martini-Klinik, Prostate Cancer Center, University Hospital Hamburg-Eppendorf, 20251 Hamburg, Germany.
⁵ Tumor and Breast Center ZeTuP St. Gallen, 9000 St. Gallen, Switzerland.

Abstract

In 2019, the scientific and medical community celebrated the 50th anniversary of the introduction of the very first marine-derived drug, Cytarabine, into clinics [...].

Publication types

Editorial
Historical Article

MeSH terms

Animals
Antineoplastic Agents / isolation & purification*
Antineoplastic Agents / pharmacology
Aquatic Organisms*
History, 21st Century
Humans
Neoplasms / drug therapy*

Substances

Antineoplastic Agents